8 months ago
IBRX
AnalystsAndres Y. MaldonadoAndres Y. Maldonado's Stock Forecasts
AnalystsAndres Y. Maldonado
Sectors:
Industries:
Analyst Ranking
Top 13%
#727 out of 5550 analysts
Average Return
+16.41%
Win Rate
42%37 out of 88
Risk vs Reward
Poor
Good
Andres Y. Maldonado's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Monopar TherapeuticsMNPR | +245.99% | $32.03 | $110.82 | 2025-08-26 - 2026-08-25 | Buy |
Immunitybio IncIBRX | +243.64% | $2.36 | $8.11 | 2025-05-12 - 2026-05-11 | Buy |
Immunitybio IncIBRX | +213.71% | $2.48 | $7.78 | 2025-04-16 - 2026-04-15 | Buy |
Immunitybio IncIBRX | +213.62% | $2.57 | $8.06 | 2025-09-10 - 2026-09-09 | Buy |
Terns Pharmaceuticals IncTERN | +203.27% | $17.43 | $52.86 | 2025-11-04 - 2026-03-25 | Buy |
Andres Y. Maldonado Analyst Color
Get additional color on Andres Y. Maldonado's coverage of popular stocks
Andres Y. Maldonado's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Zentalis Pharmaceuticals IncZNTL | 1 | Buy | $10.00 | +410.20% | Reiterates | 13 days ago |
Immunitybio IncIBRX | 12 | Buy | $15.00 | +80.94% | Reiterates | 17 days ago |
Syndax Pharmaceuticals IncSNDX | 7 | Buy | $38.00 | +178.39% | Reiterates | 19 days ago |
Verastem IncVSTM | 5 | Buy | $18.00 | +84.62% | Reiterates | a month ago |
Foghorn Therapeutics IncFHTX | 2 | Buy | $5.00 | +140.38% | Maintains | a month ago |
Scholar Rock Holding CorpSRRK | 7 | Buy | $70.00 | +59.45% | Maintains | 2 months ago |
Corbus Pharmaceuticals Holdings IncCRBP | 5 | Buy | $35.00 | +729.38% | Reiterates | 2 months ago |
Immunome IncIMNM | 3 | Buy | $40.00 | +119.66% | Reiterates | 2 months ago |
Engene Therapeutics IncENGN | 6 | Buy | $4.00 | +161.44% | Reiterates | 2 months ago |
Tscan Therapeutics IncTCRX | 3 | Hold | $1.00 | +474.71% | Downgrades | 2 months ago |
Novabridge BiosciencesNBP | 5 | Buy | $9.00 | +653.14% | Reiterates | 2 months ago |
Candel Therapeutics IncCADL | 2 | Buy | $23.00 | +176.11% | Reiterates | 3 months ago |
Erasca IncERAS | 4 | Buy | $22.00 | +53.31% | Maintains | 3 months ago |
Aura Biosciences IncAURA | 3 | Buy | $18.00 | +193.16% | Maintains | 3 months ago |
Immuneering CorpIMRX | 1 | Buy | $14.00 | +273.83% | Initiates Coverage On | 3 months ago |
Monopar TherapeuticsMNPR | 4 | Buy | $125.00 | +77.76% | Maintains | 3 months ago |
Relmada Therapeutics IncRLMD | 1 | Buy | $12.00 | +235.20% | Initiates Coverage On | 4 months ago |
Cg Oncology IncCGON | 7 | Buy | $100.00 | +54.61% | Reiterates | 5 months ago |
Sutro Biopharma IncSTRO | 3 | Buy | $50.00 | +449.45% | Maintains | 6 months ago |
Terns Pharmaceuticals IncTERN | 3 | Hold | $53.00 | +0.09% | Downgrades | 7 months ago |
Day One Biopharmaceuticals IncDAWN | 3 | Hold | $21.50 | -0.14% | Downgrades | 8 months ago |
Protara Therapeutics IncTARA | 3 | Buy | $23.00 | +827.42% | Reiterates | 9 months ago |
Werewolf Therapeutics IncHOWL | 1 | Buy | $4.00 | +305.68% | Maintains | 10 months ago |
Merus NvMRUS | 1 | Hold | $97.00 | N/A | Downgrades | a year ago |
Keros Therapeutics IncKROS | 1 | Buy | $20.00 | N/A | Maintains | a year ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.